Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...

The people behind the original protein modeling tool Alphafold have now developed a newer version, Alphafold 3, which is changing the way that this fundamental technology works. Looking at the changes ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

Google DeepMind cofounder and CEO Demis Hassabis and John Jumper, a senior researcher at the company, shared the 2024 Nobel Prize for Chemistry for their work on AlphaFold, an AI model that predicts ...

Since it was unveiled in 2020, Google DeepMind’s game-changing AI tool has helped researchers all over the world to predict the 3D structures of hundreds of millions of proteins. For nearly a decade, ...

AlphaFold shocked the scientific world by solving protein structures with accuracy once thought impossible. Researchers had spent decades trying to predict how proteins fold, often with limited ...

Pichai pointed to AI's real-world impact, noting that the Indian government used AI-powered forecasts to help farmers protect ...

WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research project that changed biology and chemistry forever. To understand what the ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...